Tumor lysis syndrome following cabazitaxel administration for metastatic castration-resistant prostate cancer: A case report.

Masashi Oshima, Shozaburou Mayumi,Kai Yazaki,Yuuki Nakamura,Tsuzumi Konishi,Kimitoshi Saito,Satoshi Washino,Tomoaki Miyagawa

IJU case reports（2019）

引用 2|浏览3

暂无评分

摘要

It is extremely important to assess the risk factors for tumor lysis syndrome and to perform active prevention procedures in order to avoid fatal outcomes. It may be beneficial to use rasburicase in patients with established tumor lysis syndrome.

查看译文

关键词

cabazitaxel,castration‐resistant prostate cancer,chemotherapy,prostate cancer,tumor lysis syndrome

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要